TL;DR: Encepheal Therapeutics is a Y Combinator Summer 2019 startup EncepHeal develops medications to treat substance abuse, starting…, currently inactive with a team of 3.
EncepHeal develops medications to treat substance abuse, starting…
Last verified:
EncepHeal is developing medications to treat substance abuse. Our first product is a small molecule therapeutic for stimulants like cocaine and methamphetamine, of which there are no FDA approved treatments. Our small molecule technology are atypical inhibitors of the dopamine transporter. Cocaine itself is an inhibitor of the same transporter. Directly reducing craving or positive reinforcement is a successful treatment strategy for addiction. Methadone or buprenorphine (Suboxone) are key examples of this for opioid use disorder. However, these types of medications can be addictive themselves. This has been a major hurdle for medication development for cocaine addiction and has led to many leaders in the addiction space to abandon the dopamine transporter as a target. At EncepHeal, we be…
Built by LemStudio
Yes. Encepheal Therapeutics was funded by Y Combinator in the Summer 2019 batch. EncepHeal develops medications to treat substance abuse, starting…
EncepHeal is developing medications to treat substance abuse. Our first product is a small molecule therapeutic for stimulants like cocaine and methamphetamine, of which there are no FDA approved treatments. Our small molecule technology are atypical inhibitors of the dopamine transporter. Cocaine itself is an inhibit…
Encepheal Therapeutics was part of Y Combinator's Summer 2019 batch.
Encepheal Therapeutics has a team of 3 people according to Y Combinator's directory.
Encepheal Therapeutics is currently listed as Inactive with a team of 3 in Y Combinator's directory.
Loading interactive view…